BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Auvelity (Dextromethorphan/bupropion) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Auvelity (Dextromethorphan/bupropion)\, f
 rom ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07766655-667@assetmemo.bio
DTSTAMP:20261121T005437Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:Auvelity (Dextromethorphan/bupropion): Phase 3 readout est. (NCT077
 66655)
DESCRIPTION:Auvelity (Dextromethorphan/bupropion)\, phase 3.\nStudy: Studyi
 ng NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)\nEstimated pri
 mary completion: December 2027. This is a ClinicalTrials.gov estimate\, no
 t a confirmed readout date\, and it can move.\nDrug page: https://assetmem
 o.bio/drug/dextromethorphan-bupropion#upcoming-events\nRegistry record: ht
 tps://clinicaltrials.gov/study/NCT07766655
URL:https://assetmemo.bio/drug/dextromethorphan-bupropion#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
